Valdilea G Veloso

Author PubWeight™ 87.76‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med 2010 50.17
2 Timing of antiretroviral therapy for HIV-1 infection and tuberculosis. N Engl J Med 2011 6.42
3 Emtricitabine-tenofovir concentrations and pre-exposure prophylaxis efficacy in men who have sex with men. Sci Transl Med 2012 6.29
4 Cost-effectiveness of genotype testing for primary resistance in Brazil. J Acquir Immune Defic Syndr 2015 1.73
5 Three postpartum antiretroviral regimens to prevent intrapartum HIV infection. N Engl J Med 2012 1.63
6 Changing mortality profile among HIV-infected patients in Rio de Janeiro, Brazil: shifting from AIDS to non-AIDS related conditions in the HAART era. PLoS One 2013 1.46
7 Changes in renal function associated with oral emtricitabine/tenofovir disoproxil fumarate use for HIV pre-exposure prophylaxis. AIDS 2014 1.34
8 Early mortality and cause of deaths in patients using HAART in Brazil and the United States. AIDS 2009 1.32
9 Epidemiology of HIV in Latin America and the Caribbean. Curr Opin HIV AIDS 2014 1.24
10 Nevirapine concentrations in newborns receiving an extended prophylactic regimen. J Acquir Immune Defic Syndr 2008 1.14
11 Comparison of clinical response to initial highly active antiretroviral therapy in the patients in clinical care in the United States and Brazil. J Acquir Immune Defic Syndr 2007 1.05
12 Immune status at presentation for HIV clinical care in Rio de Janeiro and Baltimore. J Acquir Immune Defic Syndr 2011 1.04
13 Incidence of modifying or discontinuing first HAART regimen and its determinants in a cohort of HIV-infected patients from Rio de Janeiro, Brazil. AIDS Res Hum Retroviruses 2010 1.01
14 Patterns and correlates of PrEP drug detection among MSM and transgender women in the Global iPrEx Study. J Acquir Immune Defic Syndr 2014 1.00
15 Seroprevalence and factors associated with herpes simplex virus type 2 among HIV-negative high-risk men who have sex with men from Rio de Janeiro, Brazil: a cross-sectional study. BMC Infect Dis 2009 0.96
16 Short communication: Evidences of recent decline in the expansion rate of the HIV type 1 subtype C and CRF31_BC epidemics in southern Brazil. AIDS Res Hum Retroviruses 2009 0.94
17 Immune activation and antibody responses in non-progressing elite controller individuals infected with HIV-1. J Med Virol 2009 0.92
18 Improved virologic outcomes over time for HIV-infected patients on antiretroviral therapy in a cohort from Rio de Janeiro, 1997-2011. BMC Infect Dis 2014 0.92
19 Cervical cancer screening among HIV-infected women: an economic evaluation in a middle-income country. Int J Cancer 2011 0.91
20 Anal human papillomavirus (HPV) prevalences and factors associated with abnormal anal cytology in HIV-infected women in an urban cohort from Rio de Janeiro, Brazil. AIDS Patient Care STDS 2015 0.90
21 Genetic characterization of HIV-1 BC recombinants and evolutionary history of the CRF31_BC in Southern Brazil. Infect Genet Evol 2009 0.87
22 Syphilis in HIV-infected mothers and infants: results from the NICHD/HPTN 040 study. Pediatr Infect Dis J 2015 0.87
23 Participation of women in HIV clinical trials: the IPEC-FIOCRUZ experience. HIV AIDS (Auckl) 2011 0.85
24 Maternal outcomes after HAART for the prevention of mother-to-child transmission in HIV-infected women in Brazil. Antivir Ther 2011 0.85
25 Incidence and determinants of severe morbidity among HIV-infected patients from Rio de Janeiro, Brazil, 2000-2010. Antivir Ther 2014 0.83
26 Chlamydia and Gonorrhea in HIV-Infected Pregnant Women and Infant HIV Transmission. Sex Transm Dis 2015 0.83
27 Plasma viral load threshold for sustaining intrahost HIV type 1 evolution. AIDS Res Hum Retroviruses 2007 0.83
28 Moderate prevalence of transmitted drug resistance mutations among antiretroviral-naive HIV-infected pregnant women in Rio de Janeiro, Brazil. AIDS Res Hum Retroviruses 2013 0.83
29 Chlamydia trachomatis and Neisseria gonorrhoeae in HIV-infected Pregnant Women and Adverse Infant Outcomes. Pediatr Infect Dis J 2016 0.79
30 Temporal trends and molecular epidemiology of HIV type 1 infection in Rio de Janeiro, Brazil. AIDS Res Hum Retroviruses 2013 0.78
31 Outcomes of second-line combination antiretroviral therapy for HIV-infected patients: a cohort study from Rio de Janeiro, Brazil. BMC Infect Dis 2014 0.77
32 Authors' Reply: Is Genotype Testing Really Cost-Effective for Primary Resistance in Brazil? J Acquir Immune Defic Syndr 2016 0.75
33 Unprotected sexual practices among men who have sex with women and men who have sex with men living with HIV/AIDS in Rio de Janeiro. Arch Sex Behav 2014 0.75
34 30-day readmission rates in an HIV-infected cohort from Rio de Janeiro, Brazil. J Acquir Immune Defic Syndr 2017 0.75